SCHEMBL6156924

SCHEMBL6156924

[NH]C(=O)Nc1ccc(Cl)cc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.57
NPSR1 Q6W5P4 1/20 0.57
RXFP1 Q9HBX9 1/20 0.57
RAB9A P51151 5/20 0.53
NPC1 O15118 4/20 0.53
ALDH1A1 P00352 2/20 0.53
PDK1 Q15118 1/20 0.53
PDK2 Q15119 1/20 0.53
PDK3 Q15120 1/20 0.53
PDK4 Q16654 1/20 0.53
USP2 O75604 1/20 0.53
HPGD P15428 1/20 0.53
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
ALOX15 P16050 1/20 0.51
CYP2C19 P33261 1/20 0.51
EGFR P00533 1/20 0.51
TAS1R3 Q7RTX0 1/20 0.51
TAS1R1 Q7RTX1 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5471126 0.83 RAB9A (0.65) KDM4ERAB9ANPC1ALDH1A1PDK1
SCHEMBL12919798 0.83 RAB9A (0.56) KDM4ENPSR1RXFP1RAB9ANPC1
SCHEMBL9834106 0.82 RAB9A (0.57) KDM4ENPSR1RXFP1RAB9ANPC1
SCHEMBL2090284 0.82 RAB9A (0.54) KDM4ENPSR1RXFP1RAB9ANPC1
SCHEMBL1092441 0.82 KDM4E (0.58) KDM4ENPSR1RXFP1RAB9ANPC1
SCHEMBL349268 0.81 KMT2A (0.61) NPSR1RXFP1RAB9ANPC1ALDH1A1
SCHEMBL4799616 0.80 NPC1 (0.61) KDM4ENPSR1RXFP1RAB9ANPC1
SCHEMBL4503994 0.80 ALDH1A1 (0.61) NPSR1RAB9ANPC1ALDH1A1HPGD
SCHEMBL30274478 0.80 NPC1 (0.61) KDM4ENPSR1RXFP1RAB9ANPC1
SCHEMBL29822237 0.80 KDM4E (0.66) KDM4ENPSR1RXFP1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP KDM4E 1133/4885NPSR1 2586/4885RXFP1 4729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.